Choose your sales office

News

ELITechGroup

Filter

Open filter menu
Reset
Reset

ELITechGroup Molecular inaugurates its new headquarter in Turin

Turin, 22nd December 2022 – ELITechGroup has inaugurated its new headquarters in Turin, becoming one of the largest molecular biology hubs in Europe. The inauguration was held on Friday 16th December in the presence of institutional figures, collaborators, and employees. At the ribbon cutting, Michela Favaro – Deputy Mayor of…
READ MORE

ELITechGroup’s Vitamin D reagents; ready-to-use chemistry for efficiency

Vitamin D is a fat-soluble steroid hormone that is required for the intestinal absorption of calcium, maintenance of calcium homeostasis, and protection against osteomalacia i.e. softening of the bones. Vitamin D deficiency can lead to loss of bone density which can contribute to osteoporosis (reduction in bone mass) and fractures…
READ MORE

ELITechGroup’s Cholinesterase – an economical option for low-volume testing

The primary role of Cholinesterase in Clinical Diagnostics is to detect or monitor an acquired or inherited pseudocholinesterase deficiency. Pseudocholinesterase deficiency is a condition that causes increased sensitivity to certain muscle relaxant drugs used during general anesthesia (choline esters). These drugs relax the muscles used for movement, including those used…
READ MORE

ELITe InGenius™ nominated for Scientists’ Choice Awards®!

  ELITe InGenius™ nominated for Scientists’ Choice Awards! Each year the Scientists’ Choice Awards® celebrates the laboratory products and manufacturers that make a difference to the industry. SelectScience began the Scientists’ Choice Awards® in 2007 to enable scientists to voice their opinions on the best laboratory products. Scientists are then…
READ MORE

ELITechGroup receives CE mark

ITALY, Torino, December 9th, 2021. ELITechGroup announced today that its SARS-CoV-2 Extended ELITe MGB® Kit reliably differentiates the SARS-CoV-2 Omicron (B.1.1.529) variant from other variants of concern. The in-silico analysis was confirmed by testing patient samples positive for different SARS-CoV-2 variants including Omicron. ELITechGroup is pleased to offer the SARS-CoV-2…
READ MORE

Our new Molecular MDR/MTB multiplex assay

Een high performance based on our MGB® technology: – MTB complex: M.tuberculosis, M.africanum, M.bovis, M.canetti, M.microti, M.caprae. – MGB resistence: Rifampicine en Izoniazide. – Ultra sensitive: 6CFU/ml! – Ready to use monoreagent. In combination with our RT-PCR Sample-to-Result ELITe InGenius the most flexible solution for the diagnosis of Tuberculosis. “
READ MORE

ELITechGroup and InfanDx AG to Collaborate on the Development and Manufacturing of HypoxE® Neonatal Care Test for Clinical Laboratories

HypoxE® Test allows for the early detection of Hypoxic-Ischemic Encephalopathy (HIE) caused by lack of oxygen during birth ELITechGroup to provide contract development and manufacturing services for HypoxE® IVD Tests designed for Selectra Pro family of clinical chemistry analyzers Chicago, IL, USA, July 27, 2022 – ELITechGroup and InfanDx AG…
READ MORE

IVDR compliance at ELITechGroup Clinical Chemistry

As a European-based (EU) manufacturer of IVD products, used in clinical diagnostic laboratories throughout the world, the introduction of the EU’s IVDR is of paramount importance for ELITechGroup’s Clinical Systems division. European Invitro Diagnostic Medical Device Regulations (IVDR) The IVDR will replace the existing In Vitro Diagnostic Medical Devices Directive…
READ MORE

NEW ELITechGroup Lactate Reagent

ELITechGroup Clinical Systems is pleased to announce the introduction of another new reagent, Lactate, to the growing range of reagents for the Selectra Pro and Mach systems. Lactate is a metabolite of glucose, produced during conditions of insufficient oxygen supply (e.g. rapid exercise). Most Lactate is produced by skeletal muscle…
READ MORE

ELITechGroup soutient AIDES & La ligue contre le cancer

Puteaux, France, le 15 Avril 2022, (14h CEST) ELITechGroup, fabricant et distributeur d’équipements et de réactifs de diagnostic in vitro, a annoncé apporter son soutien en offrant une aide financière auprès de deux associations françaises : AIDES et La Ligue contre le canc ELITechGroup, acteur incontournable de la biologie moléculaire,…
READ MORE

ELITechGroup supports AIDES & La Ligue contre le cancer

Puteaux, France, April 28th, 2022 – ELITechGroup, manufacturer and distributor of in vitro diagnostic instruments and reagents, has announced its charitable contributions to two French associations: AIDES and La Ligue contre le cancer. ELITechGroup, a key player in molecular biology diagnostics and clinical chemistry, brings together the expertise of innovative…
READ MORE

ELITechGroup’s donation to support Ukraine

Turin, 5th April, 2022 – ELITechGroup donated € 30,000 to provide emergency aid to Ukraine in response to the humanitarian crisis. Given the dramatic situation in Ukraine, ELITechGroup took immediate action to collaborate with SERMIG, a non-profit organisation based in Turin, Italy, with more than 50 years of experience in…
READ MORE

ELITechGroup celebrates the installation of the 1000th ELITe InGenius® system

Turin, 23rd December, 2021 – It is with great satisfaction that ELITechGroup announces the installation of the 1000th ELITe InGenius® system. This milestone – achieved only 5 years after the launch of the product – clearly demonstrates the worldwide success of the company’s fully automated sample-to-result Real Time PCR platform.…
READ MORE

A PCR kit that differentiates the SARS-CoV-2 Omicron Variant

Bothell, WA December 10, 2021 ELITechGroup MDx LLC (“ELITechGroup MDx”) announced today that its Research Use Only (RUO) SARS-CoV-2 Extended test kit reliably differentiates the SARS-CoV-2 Omicron (B.1.1.529) variant from other variants of concern. The in-silico analysis was confirmed by testing patient samples positive for different SARS-CoV-2 variants including Omicron.…
READ MORE

The first PCR kit that differentiates the SARS-CoV-2 Omicron Variant

ITALY, Torino, December 9th, 2021. ELITechGroup announced today that its SARS-CoV-2 Extended ELITe MGB® Kit reliably differentiates the SARS-CoV-2 Omicron (B.1.1.529) variant from other variants of concern. The in-silico analysis was confirmed by testing patient samples positive for different SARS-CoV-2 variants including Omicron. ELITechGroup is pleased to offer the SARS-CoV-2…
READ MORE

ELITechGroup announces the launch of ELITe BeGenius®

ITALY, Torino, October 12th, 2021. It is with great satisfaction that ELITechGroup announces the launch of ELITe BeGenius®, the new CE-IVD stand-alone “Sample – to – Result” Real Time PCR solution. ELITe BeGenius® makes molecular biology universally accessible thanks to its compact footprint, exceptional ease-of-use, and total automation. Tailorable for…
READ MORE